 Among the expanding world of New Psychoactive Substances Designer Medicines are designed to mimic psychoactive drugs and might lead to adverse events of various severity . The DM category includes designer benzodiazepines phenmetrazine modafinil methylphenidate analogs and novel synthetic opioids .

@highlight Assessment of the changes in NPS related complications in France from 2009 to 2017.
@highlight Designer medicines are increasingly used and are associated with high risk of serious effects.
@highlight Specific monitoring of designer medicines must be put in place.
